BACKGROUND: Community-acquired pneumonia (CAP) causes significant morbidity and mortality, but Swiss data are limited. We analyzed the Swiss CAPNETZ cohort to describe patient characteristics, pathogens, diagnostics, and outcomes. METHODS: Adults with CAP were prospectively enrolled between 2010 and 2022 at two tertiary hospitals. Data on demographics, comorbidities, microbiology, and outcomes were collected. Mortality was assessed at 28 and 180 days. RESULTS: Among 478 patients, 97.7% were hospitalized (median 7 days), and 76.4% had
- Etienne, S.
- Albrich, W. C.
- Pletz, M. W.
- Panning, M.
- Suarez Domenech, V.
- Eberhardt, F.
- Barten-Neiner, G.
- Stolz, D.
Keywords
- Humans
- *Community-Acquired
- Infections/microbiology/mortality/epidemiology/virology/diagnosis
- Switzerland/epidemiology
- Male
- Female
- Aged
- Middle Aged
- Adult
- Prospective Studies
- Aged, 80 and over
- *Pneumonia/microbiology/mortality/epidemiology
- COVID-19/epidemiology
- Cohort Studies
- Hospitalization
- *Pneumonia, Bacterial/microbiology/mortality
- Immunocompromised Host
- Community-Acquired Pneumonia
- Etiololgy
- Haemophilus influenzae
- Immunosupression
- Polymerase chain reaction
- Streptococcus pneumoniae
